CAS No.: 910463-68-2
Semaglutide/司美格鲁肽 Catalog No. CSN21104
Synonyms: 索马鲁肽;司美格鲁肽
Semaglutide is an analog of human GLP-1 with long-acting effect over the other GLP-1Ras.
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 作用机制
动物研究 剂量 Rat: 0.15 mg/kg, 0.48 mg/kg[4] (s.c.)
给药途径 s.c.
动物药代数据 Animal Mice[5] Rats[5] Monkeys[5] Dose 1 mg/kg 1 mg/kg 1 mg/kg Administration s.c. s.c. s.c. Cavg 927 nmol/l 2080 nmol/l Cmean 522 nmol/l T1/2 7.5 h 12 h 54 h Tau 24 h 24 h 72 h Tmax 4 h 4 h 12 h Cmax 1040 nmol/l 1340 nmol/l 2860 nmol/l AUCtau 12500 h·nmol/l 23700 h·nmol/l 150000 h·nmol/l - 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT03707990 Obesity and Overweight Phase 1 Recruiting September 11, 2019 United States, Arizona ... more >> Novo Nordisk Investigational Site Recruiting Tempe, Arizona, United States, 85283 Collapse << NCT00851773 Diabetes Heal... more >>thy Collapse << Phase 1 Completed - United Kingdom ... more >> London SW, United Kingdom, 17 0RE Collapse << NCT01686945 Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << Phase 1 Completed - Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << - 更多
- 参考文献
- [1] Lau J, Bloch P, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. J Med Chem. 2015 Sep 24;58(18):7370-80.
- [2] Zhang L, Zhang L, et al. Semaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease. J Parkinsons Dis. 2019;9(1):157-171.
- [3] Rakipovski G, Rolin B, et al. The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE-/- and LDLr-/- Mice by a Mechanism That Includes Inflammatory Pathways. JACC Basic Transl Sci. 2018 Nov 21;3(6):844-857.
- [4] Semaglutide
- [5] Semaglutide
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 910463-68-2 | 储存条件 |
|
|
| 分子式 | C187H291N45O59 | 运输 | 蓝冰 | |
| 分子量 | 4113.58 | 别名 | 索马鲁肽;司美格鲁肽 |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
|---|
| NCT03707990 | Obesity and Overweight | Phase 1 | Recruiting | September 11, 2019 | United States, Arizona ... more >> Novo Nordisk Investigational Site Recruiting Tempe, Arizona, United States, 85283 Collapse << |
| NCT00851773 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> London SW, United Kingdom, 17 0RE Collapse << |
| NCT01686945 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT00813020 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT01619345 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> Nottingham, United Kingdom, NG11 6JS Collapse << |
| NCT00833716 | Diabetes Diab... more >>etes Mellitus, Type 2 Renal Impairment Collapse << | Phase 1 | Completed | - | United States, Florida ... more >> Novo Nordisk Investigational Site Miami, Florida, United States, 33014 Novo Nordisk Investigational Site Orlando, Florida, United States, 32806 United States, Tennessee Novo Nordisk Investigational Site Knoxville, Tennessee, United States, 37920 Collapse << |
| NCT03144271 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
| NCT03659682 | Parkinson Disease | Phase 2 | Not yet recruiting | December 31, 2024 | - |
| NCT01572753 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT03466567 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT00696657 | - | - | Completed | - | - |
| NCT00696657 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 2 | Completed | - | - |
| NCT02453711 | Metabolism and Nutrition Disor... more >>der Obesity Collapse << | Phase 2 | Completed | - | - |
| NCT03061214 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Active, not recruiting | April 17, 2019 | - |
| NCT02845219 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT02070510 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT01923181 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 2 | Completed | - | - |
| NCT03018028 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | Japan ... more >> Novo Nordisk Investigational Site Akita-shi, Akita, Japan, 010 8543 Novo Nordisk Investigational Site Arakawaku, Tokyo, Japan, 116-0012 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Minato-ku, Tokyo, Japan, 108-0075 Novo Nordisk Investigational Site Naka-shi, Japan, 311 0113 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-shi, Gunma, Japan, 373-0036 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sendaishi, Miyagi, Japan, 980-8574 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Collapse << |
| NCT03010475 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> Novo Nordisk Investigational Site Harrow, United Kingdom, HA1 3UJ Collapse << |
| NCT01930188 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02607865 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02461589 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 2 | Completed | - | - |
| NCT01324505 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
| NCT02461589 | - | - | Completed | - | - |
| NCT01272973 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT02079870 | Diabetes Meta... more >>bolism and Nutrition Disorder Obesity Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9LH Collapse << |
| NCT01866748 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT03021187 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02305381 | - | - | Completed | - | - |
| NCT02212067 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
| NCT02022254 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Collapse << |
| NCT02064348 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT02305381 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02648204 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02054897 | - | - | Completed | - | - |
| NCT03015220 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | Japan ... more >> Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Arakawaku, Tokyo, Japan, 116-0012 Novo Nordisk Investigational Site Chiba-shi, Chiba, Japan, 260-0804 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 104-0061 Novo Nordisk Investigational Site Iruma-shi, Saitama, Japan, 358 0011 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kawagoe-shi, Saitama, Japan, 350 0851 Novo Nordisk Investigational Site Kawaguchi-city Saitama, Japan, 332855 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Kurashiki-shi, Okayama, Japan, 701 0192 Novo Nordisk Investigational Site Kyoto-shi, Kyoto, Japan, 601 1495 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Ota-shi, Gunma, Japan, 373-0036 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 004-0004 Novo Nordisk Investigational Site Sapporo-shi, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinagawa-ku, tokyo, Japan, 141-0032 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Tokyo, Japan, 144-0051 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Toshima-ku, Tokyo, Japan, 171-0021 Novo Nordisk Investigational Site Yamato-shi, Kanagawa, Japan, 242-0004 Novo Nordisk Investigational Site Yokohama-shi Kanagawa, Japan, 232-0064 Collapse << |
| NCT02906930 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02849080 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Active, not recruiting | April 5, 2019 | - |
| NCT02863419 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02863328 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02970942 | Hepatobiliary Disorders ... more >> Non-alcoholic Steatohepatitis Collapse << | Phase 2 | Active, not recruiting | April 2, 2020 | - |
| NCT02648204 | - | - | Completed | - | - |
| NCT02692716 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02243098 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT02773381 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | United Kingdom ... more >> Novo Nordisk Investigational Site Leeds, United Kingdom, LS2 9LH Collapse << |
| NCT02827708 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02054897 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02249910 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT01720446 | - | - | Completed | - | - |
| NCT02254291 | - | - | Completed | - | - |
| NCT01720446 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02207374 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | Japan ... more >> Novo Nordisk Investigational Site Akita-shi, Akita, Japan, 010 8543 Novo Nordisk Investigational Site Annaka-shi, Gunma, Japan, 379 0116 Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 078 8510 Novo Nordisk Investigational Site Bunkyo-ku, Tokyo, Japan, 113 8431 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0002 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 104-0061 Novo Nordisk Investigational Site Fukuoka, Japan, 812 0025 Novo Nordisk Investigational Site Higashiosaka-shi, Osaka, Japan Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kitakyushu-shi, Fukuoka, Japan, 800 0252 Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan, 963 8851 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Kyoto-shi, Kyoto, Japan, 615 8125 Novo Nordisk Investigational Site Mito-shi, Ibaraki, Japan Novo Nordisk Investigational Site Miyazaki-shi, Japan, 880 0034 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Nishinomiya-shi, Hyogo, Japan, 663-8501 Novo Nordisk Investigational Site Okawa-shi, Fukuoka, Japan, 831 0016 Novo Nordisk Investigational Site Okayama-shi, Okayama, Japan, 700 8505 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 532 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan, 323 0022 Novo Nordisk Investigational Site Saga-shi,Saga, Japan, 849 0937 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 062 0007 Novo Nordisk Investigational Site Sendai-shi, Japan, 980 0021 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Shizuoka-shi, Japan, 424 0853 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 103-0028 Novo Nordisk Investigational Site Tokyo, Japan, 123-0845 Novo Nordisk Investigational Site Ube-shi, Yamaguchi, Japan Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Collapse << |
| NCT03136484 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02254291 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | Japan ... more >> Novo Nordisk Investigational Site Asahikawa-shi, Hokkaido, Japan, 070 0002 Novo Nordisk Investigational Site Chitose, Hokkaido, Japan, 066-0032 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 103-0027 Novo Nordisk Investigational Site Chuo-ku Tokyo, Japan, 104-0031 Novo Nordisk Investigational Site Chuo-ku, Tokyo, Japan, 103 0027 Novo Nordisk Investigational Site Ebina-shi, Japan, 243 0432 Novo Nordisk Investigational Site Izumisano-shi, Japan, 598 0048 Novo Nordisk Investigational Site Kashiwara-shi, Osaka, Japan, 582 0005 Novo Nordisk Investigational Site Katsushika-ku, Tokyo, Japan, 125 0054 Novo Nordisk Investigational Site Kumamoto-shi,Kumamoto, Japan, 862 0976 Novo Nordisk Investigational Site Naka-shi, Ibaraki, Japan, 311 0113 Novo Nordisk Investigational Site Nishinomiya-shi, Hygo, Japan, 662 0971 Novo Nordisk Investigational Site Oita-shi, Japan, 870 0039 Novo Nordisk Investigational Site Osaka-shi, Osaka, Japan, 553 0003 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan, 144 0035 Novo Nordisk Investigational Site Ota-ku, Tokyo, Japan Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060 0062 Novo Nordisk Investigational Site Sapporo-shi, Hokkaido, Japan, 060-0001 Novo Nordisk Investigational Site Shimotsuke-shi, Tochigi, Japan, 329 0433 Novo Nordisk Investigational Site Shinjuku-ku, Tokyo, Japan, 160-0008 Novo Nordisk Investigational Site Suita-shi, Osaka, Japan, 565-0853 Novo Nordisk Investigational Site Takatsuki-shi, Osaka, Japan, 569 1096 Novo Nordisk Investigational Site Tokyo, Japan, 181-0013 Novo Nordisk Investigational Site Yokohama, Kanagawa, Japan, 236-0004 Novo Nordisk Investigational Site Yokohama-shi, Japan, 235 0045 Collapse << |
| NCT01885208 | - | - | Completed | - | - |
| NCT02147431 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Austria ... more >> Novo Nordisk Investigational Site Graz, Austria, 8010 Collapse << |
| NCT02128932 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT03191396 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT03086330 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT02128932 | - | - | Completed | - | - |
| NCT02920385 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT03724981 | Diabetes Mellitus, Type 2 | Phase 4 | Not yet recruiting | March 15, 2019 | United States, Maryland ... more >> Evidera Not yet recruiting Bethesda, Maryland, United States, 20814 Principal Investigator: Louis Matza Collapse << |
| NCT01885208 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 3 | Completed | - | - |
| NCT03689374 | Diabetes Mellitus, Type 2 | Phase 3 | Recruiting | November 13, 2020 | - |
| NCT03357380 | Hepatobiliary Disorders ... more >> Non-alcoholic Fatty Liver Disease Collapse << | Phase 1 | Active, not recruiting | March 27, 2020 | Germany ... more >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
| NCT02172313 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT02557620 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Collapse << |
| NCT03552757 | Obesity Overw... more >>eight Collapse << | Phase 3 | Recruiting | May 4, 2020 | - |
| NCT03600480 | Obesity Overw... more >>eight Collapse << | Phase 1 | Recruiting | January 22, 2020 | United States, Kansas ... more >> Novo Nordisk Investigational Site Recruiting Overland Park, Kansas, United States, 66212 Collapse << |
| NCT02146079 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Japan ... more >> Novo Nordisk Investigational Site Tokyo, Japan, 130-0004 Collapse << |
| NCT01766245 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 13353 Collapse << |
| NCT02014259 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Czechia ... more >> Novo Nordisk Investigational Site Hradec Králové, Czechia, 50005 Novo Nordisk Investigational Site Praha 7, Czechia, 17000 Hungary Novo Nordisk Investigational Site Budapest, Hungary, 1076 Novo Nordisk Investigational Site Budapest, Hungary, 1115 Collapse << |
| NCT03596450 | Diabetes Mellitus, Type 2 | Phase 4 | Recruiting | November 19, 2021 | United States, California ... more >> Novo Nordisk Investigational Site Not yet recruiting Monterey, California, United States, 93940 Novo Nordisk Investigational Site Not yet recruiting San Jose, California, United States, 95148 Novo Nordisk Investigational Site Not yet recruiting Tulare, California, United States, 93274 United States, Connecticut Novo Nordisk Investigational Site Not yet recruiting Milford, Connecticut, United States, 06460 United States, Georgia Novo Nordisk Investigational Site Not yet recruiting Lilburn, Georgia, United States, 30047 Novo Nordisk Investigational Site Not yet recruiting Sandersville, Georgia, United States, 31082 Novo Nordisk Investigational Site Not yet recruiting Savannah, Georgia, United States, 31406 Novo Nordisk Investigational Site Recruiting Statesboro, Georgia, United States, 30461 Novo Nordisk Investigational Site Not yet recruiting Stockbridge, Georgia, United States, 30281 Novo Nordisk Investigational Site Not yet recruiting Swainsboro, Georgia, United States, 30401 United States, Kentucky Novo Nordisk Investigational Site Not yet recruiting Covington, Kentucky, United States, 41011 Novo Nordisk Investigational Site Not yet recruiting Owensboro, Kentucky, United States, 42303 United States, Virginia Novo Nordisk Investigational Site Not yet recruiting Chatham, Virginia, United States, 24531 Novo Nordisk Investigational Site Not yet recruiting Colonial Heights, Virginia, United States, 23834 Novo Nordisk Investigational Site Not yet recruiting Falls Church, Virginia, United States, 22044 Novo Nordisk Investigational Site Not yet recruiting Lynchburg, Virginia, United States, 24501 Novo Nordisk Investigational Site Not yet recruiting Warrenton, Virginia, United States, 20186 Collapse << |
| NCT02231684 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Berlin, Germany, 14050 Collapse << |
| NCT02016911 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Czechia ... more >> Novo Nordisk Investigational Site Praha 10, Czechia, 10034 Novo Nordisk Investigational Site Praha 7, Czechia, 17000 Poland Novo Nordisk Investigational Site Bialystok, Poland, 15-879 Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wolomin, Poland, 05-200 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 83101 Collapse << |
| NCT03574584 | Metabolism and Nutrition Disor... more >>ders Overweight or Obesity Collapse << | Phase 1 | Recruiting | August 22, 2019 | United States, Nebraska ... more >> Novo Nordisk Investigational Site Recruiting Lincoln, Nebraska, United States, 68502 Collapse << |
| NCT02060266 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Netherlands ... more >> Novo Nordisk Investigational Site Groningen, Netherlands, 9728 NZ Collapse << |
| NCT02210871 | Diabetes Diab... more >>etes Mellitus, Type 2 Hepatic Impaired Collapse << | Phase 1 | Completed | - | Poland ... more >> Novo Nordisk Investigational Site Warszawa, Poland, 02-507 Novo Nordisk Investigational Site Wolomin, Poland, 05-200 Slovakia Novo Nordisk Investigational Site Bratislava, Slovakia, 83101 Novo Nordisk Investigational Site Bratislava, Slovakia, 833 05 Collapse << |
| NCT02161588 | Diabetes Diab... more >>etes Mellitus, Type 2 Healthy Collapse << | Phase 1 | Completed | - | Japan ... more >> Tokyo, Japan, 130-0004 Collapse << |
| NCT03548987 | Metabolism and Nutrition Disor... more >>der Obesity Collapse << | Phase 3 | Active, not recruiting | March 23, 2020 | - |
| NCT03611322 | Diabetes Mellitus, Type 2 | Phase 1 | Active, not recruiting | January 2, 2019 | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 10117 Collapse << |
| NCT03693430 | Overweight Ob... more >>esity Collapse << | Phase 3 | Recruiting | March 19, 2021 | - |
| NCT03638778 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT03611582 | Overweight Ob... more >>esity Collapse << | Phase 3 | Active, not recruiting | May 6, 2020 | - |
| NCT03548935 | Metabolism and Nutrition Disor... more >>der Overweight or Obesity Collapse << | Phase 3 | Recruiting | April 20, 2020 | - |
| NCT03574597 | Overweight Ob... more >>esity Collapse << | Phase 3 | Recruiting | September 28, 2023 | - |
| NCT03457012 | - | - | Enrolling by invitation | November 25, 2019 | Canada, Ontario ... more >> Novo Nordisk Investigational Site Cambridge, Ontario, Canada, N1R 7L6 Collapse << |
| NCT03288740 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | China ... more >> Novo Nordisk Investigational Site Beijing, China, 100730 Collapse << |
| NCT03631186 | - | - | Enrolling by invitation | May 25, 2020 | Switzerland ... more >> Novo Nordisk Investigational Site Ascona, Switzerland, 6612 Novo Nordisk Investigational Site Baden, Switzerland, 5400 Novo Nordisk Investigational Site Baden, Switzerland, 5404 Novo Nordisk Investigational Site Basel, Switzerland, 4031 Novo Nordisk Investigational Site Bellinzona, Switzerland, 6500 Novo Nordisk Investigational Site Binningen, Switzerland, 4102 Novo Nordisk Investigational Site Blonay, Switzerland, 1807 Novo Nordisk Investigational Site Chiasso, Switzerland, 6830 Novo Nordisk Investigational Site Estavayer-le-Lac, Switzerland, 1470 Novo Nordisk Investigational Site Frauenfeld, Switzerland, 8500 Novo Nordisk Investigational Site Fribourg, Switzerland, 1700 Novo Nordisk Investigational Site Genève, Switzerland, 1206 Novo Nordisk Investigational Site Kleinhüningen, Switzerland, 4057 Novo Nordisk Investigational Site Lausanne, Switzerland, 1010 Novo Nordisk Investigational Site Lugano, Switzerland, 6900 Novo Nordisk Investigational Site Nürensdorf, Switzerland, 8309 Novo Nordisk Investigational Site Olten, Switzerland, 4600 Novo Nordisk Investigational Site Schaffhausen, Switzerland, 8208 Novo Nordisk Investigational Site Solothurn, Switzerland, 4500 Novo Nordisk Investigational Site St. Gallen, Switzerland, 9016 Novo Nordisk Investigational Site Viganello, Switzerland, 6962 Novo Nordisk Investigational Site Zürich, Switzerland, 8008 Novo Nordisk Investigational Site Zürich, Switzerland, 8046 Collapse << |
| NCT03598621 | Diabetes Mellitus, Type 2 | Phase 1 | Active, not recruiting | January 17, 2019 | Germany ... more >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
| NCT02249871 | Diabetes Heal... more >>thy Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Berlin, Germany, 14050 Collapse << |
| NCT03648281 | - | - | Enrolling by invitation | June 22, 2020 | Denmark ... more >> Novo Nordisk Investigational Site Søborg, Denmark Collapse << |
| NCT02877355 | Diabetes Diab... more >>etes Mellitus, Type 2 Collapse << | Phase 1 | Completed | - | Germany ... more >> Novo Nordisk Investigational Site Mainz, Germany, 55116 Novo Nordisk Investigational Site Neuss, Germany, 41460 Collapse << |
